Target intelligence / Profile preview

Ribonucleotide Reductase R2 Subunit (RRM2)

Target
RRM2
Molecular classification
Enzyme
01

Overview

The ribonucleotide reductase R2 subunit (RRM2, M2, or R2) is a critical component of the ribonucleotide reductase (RNR) enzyme complex, which catalyzes the reduction of ribonucleotides to deoxyribonucleotides—the essential precursors for DNA synthesis and repair. It is a homodimer, where each monomer harbors a dinuclear iron center that is crucial for generating and stabilizing a tyrosyl radical, which initiates the radical-based chemistry required for nucleotide reduction. Overexpression or dysregulation of RRM2 has been linked with increased tumorigenesis, cancer progression, and drug resistance. It is a therapeutic target in oncology.

Other names
M2R2Ribonucleside-diphosphate reductase small chainRR small chainRR regulatory subunitRNR-RBRegulatory Subunit MII/MIIb/RB
02

Mechanism of action

Inhibition of ribonucleotide reductase activity by scavenging tyrosyl radicals, thereby blocking DNA synthesis.

03

Biological functions

DNA synthesisDNA repairCell cycleCell proliferation
04

Disease associations

CancerDrug resistance
05

Safety considerations

Myelosuppression (with Hydroxyurea)Potential for off-target effects in rapidly dividing cells
06

Interacting drugs

Hydroxyurea
07

Biomarkers

RRM2 overexpression (prognostic marker)RRM2 expression levels (treatment response)

Beyond the preview

Go deeper on Ribonucleotide Reductase R2 Subunit (RRM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribonucleotide Reductase R2 Subunit (RRM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call